Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Expert Rev Clin Immunol. 2023 May 11;19(7):689–692. doi: 10.1080/1744666X.2023.2207823

Figure 1:

Figure 1:

Proposed therapeutic approach based on the 2019 American College of Rheumatology recommendations for the treatment of JIA associated uveitis.

List of abbreviations: APC antigen presenting cell, CAU chronic anterior uveitis, d daily, dp drops, EB endothelial barrier, os oral, JAKi Janus Kinase inhibitor, JIA Juvenile Idiopathic Arthritis, MTX Methotrexate, PA prednisone acetate, sc subcutaneous, TNFi Tumor Necrosis factor alpha inhibitor.